Literature DB >> 21762644

Peritoneal dialysis for patients suffering from severe heart failure.

N G Sotirakopoulos1, I M Kalogiannidou, M E Tersi, K S Mavromatidis.   

Abstract

Over a period of 6.5 years, we treated 19 patients, all of whom suffered from severe heart failure and various stages of chronic kidney disease, excluding those with end-stage kidney failure. Before peritoneal catheter implantation, all patients had ascites, dyspnea, orthopnea, and an ejection fraction ranging from 20 to 45%. Seven of them (7/19) were able to take care of themselves, 9/19 needed assistance for their daily activities, and the remaining 3 were bedridden. All of them needed hospitalization 1 - 3 times/month during the year before the initiation of continuous ambulatory peritoneal dialysis (CAPD). With peritoneal dialysis, daily ultrafiltrate volume ranged from 500 to 3,000 ml and, after an average of 2 months of peritoneal dialysis, body weight decreased significantly (74.7 ± 13 vs. 69.7 ± 10.2, p = 0.02). At the same time, diuresis improved significantly, and this allowed a reduction in the dose of diuretics. Dyspnea and orthopnea improved significantly in all patients. The patients' degree of self-care and ability to sleep lying flat improved significantly as the need for hospitalization declined. Before peritoneal dialysis, patients were hospitalized for 5 - 20 days/month for pulmonary edema or overhydration, whereas with peritoneal dialysis, nobody was hospitalized for these causes (chi2, p = 0.0001). Ejection fraction also improved in all of them (28.6 ± 8.6 vs. 36.8 ± 12.5%, p = 0.0001). Actual survival of our patients ranged from 6 to 86 months (mean ± SD = 24.6 ± 20.8). Actuarial survival was 68% at 1 year and 42% at 2 years. During peritoneal dialysis we observed only two episodes of peritonitis. Four patients developed a severe episode of hypotension during implantation of the catheters from the sudden removal of 4 - 6 l of ascitic fluid. We conclude that peritoneal dialysis is a good method for the treatment of congestive heart failure because it increases the quality of life and life expectancy in patients with poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762644     DOI: 10.5414/cn107026

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  9 in total

1.  Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics.

Authors:  Cécile Courivaud; Amir Kazory; Thomas Crépin; Raymond Azar; Catherine Bresson-Vautrin; Jean-Marc Chalopin; Didier Ducloux
Journal:  Perit Dial Int       Date:  2013-09-01       Impact factor: 1.756

Review 2.  Peritoneal dialysis in patients with refractory congestive heart failure: a systematic review.

Authors:  Renhua Lu; María-Jimena Muciño-Bermejo; Leonardo Claudino Ribeiro; Enrico Tonini; Carla Estremadoyro; Sara Samoni; Aashish Sharma; José de Jesús Zaragoza Galván; Carlo Crepaldi; Alessandra Brendolan; Zhaohui Ni; Mitchell H Rosner; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2015-04       Impact factor: 2.041

Review 3.  Peritoneal ultrafiltration in congestive heart failure-findings reported from its application in clinical practice: a systematic review.

Authors:  Giusto Viglino; Loris Neri; Mauro Feola
Journal:  J Nephrol       Date:  2015-01-14       Impact factor: 3.902

Review 4.  Peritoneal Dialysis for Heart Failure.

Authors:  Harish Puttagunta; Stephen G Holt
Journal:  Perit Dial Int       Date:  2015-11       Impact factor: 1.756

5.  The clinical status and survival in elderly dialysis: example of the oldest region of France.

Authors:  Florence Glaudet; Carine Hottelart; Julien Allard; Vincent Allot; Frédérique Bocquentin; Rémy Boudet; Béatrice Champtiaux; Jean Pierre Charmes; Monica Ciobotaru; Zara Dickson; Marie Essig; Philippe Honoré; Céline Lacour; Christian Lagarde; Maria Manescu; Pierre Peyronnet; Jean Michel Poux; Jean Philippe Rerolle; Michel Rincé; Cécile Couchoud; Jean Claude Aldigier
Journal:  BMC Nephrol       Date:  2013-06-25       Impact factor: 2.388

6.  The role of peritoneal ultrafiltration in the treatment of refractory congestive heart failure.

Authors:  Sara Samoni; Ilaria Petrucci; Giordano Fumagalli; Costanza Tattanelli; Mario Meola; Daniela Palmarini; Carlo Donadio
Journal:  JRSM Open       Date:  2015-03-18

7.  Peritoneal Ultrafiltration in the Long-Term Treatment of Chronic Heart Failure Refractory to Pharmacological Therapy.

Authors:  Ewa Wojtaszek; Agnieszka Grzejszczak; Stanislaw Niemczyk; Jolanta Malyszko; Joanna Matuszkiewicz-Rowińska
Journal:  Front Physiol       Date:  2019-03-28       Impact factor: 4.566

8.  Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis.

Authors:  Margarita Kunin; Vered Carmon; Michael Arad; Nomy Levin-Iaina; Dov Freimark; Eli J Holtzman; Dganit Dinour
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

Review 9.  The Peritoneal Membrane-A Potential Mediator of Fibrosis and Inflammation among Heart Failure Patients on Peritoneal Dialysis.

Authors:  Margarita Kunin; Pazit Beckerman
Journal:  Membranes (Basel)       Date:  2022-03-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.